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Epigenetic silencing of Oct4 by a complex
containing SUV39H1 and Oct4 pseudogene lncRNA
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Pseudogene-derived, long non-coding RNAs (lncRNAs) act as epigenetic regulators of gene
expression. Here we present a panel of new mouse Oct4 pseudogenes and demonstrate that
the X-linked Oct4 pseudogene Oct4P4 critically impacts mouse embryonic stem cells
(mESCs) self-renewal. Sense Oct4P4 transcription produces a spliced, nuclear-restricted
lncRNA that is efﬁciently upregulated during mESC differentiation. Oct4P4 lncRNA forms a
complex with the SUV39H1 HMTase to direct the imposition of H3K9me3 and HP1a to the
promoter of the ancestral Oct4 gene, located on chromosome 17, leading to gene silencing
and reduced mESC self-renewal. Targeting Oct4P4 expression in primary mouse embryonic
ﬁbroblasts causes the re-acquisition of self-renewing features of mESC. We demonstrate that
Oct4P4 lncRNA plays an important role in inducing and maintaining silencing of the ancestral
Oct4 gene in differentiating mESCs. Our data introduces a sense pseudogene–lncRNA-based
mechanism of epigenetic gene regulation that controls the cross-talk between pseudogenes
and their ancestral genes.
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ct4 is a member of the POU family of transcription
factors that controls early embryonic differentiation
and is essential to maintain mESC pluripotency and
self-renewal1–6. Oct4 is expressed in germ cells, the inner cell
mass of pre-implantation embryos, embryonic stem cells (ESC)
but also in different types of human cancer7–10. Oct4 is essential
to establish the core transcriptional network maintaining
pluripotency and self-renewal in mESCs1–4. Importantly,
ectopic expression of the key mESC self-renewal transcription
factors Oct4, Sox2, Klf4 and c-Myc induces pluripotency in
differentiated cells, resulting in induced pluripotent stem (iPS)
cells11. Out of this basic set of transcription factors, Oct4 is
the only indispensible factor for iPS cell generation11,12.
This highlights a central role of Oct4 for ESC pluripotency and
self-renewal. Given the key role of Oct4 in mESC self-renewal,
discovering pathways that control Oct4 expression has primary
importance. Induction of ESC differentiation leads to rapid
transcriptional and epigenetic silencing of Oct4 (refs 13–18).
Other pathways that regulate Oct4 expression involve post-
translational modiﬁcations or miRNAs19–25. A growing body of
evidence indicates an important role of pseudogene-derived
RNAs in regulating the expression of their ancestral gene, either
by modulating chromatin structure via anti-sense transcription,
short interfering RNA (siRNA) formation or sponging miRNAs
from their ancestral genes by acting as competing endogenous
RNAs (ceRNAs)26–32. Recent studies demonstrate the existence
of various human OCT4 pseudogenes and anticipate a relevance
for pseudogene-derived ncRNAs in the regulation of the ancestral
OCT4 gene in ESCs but also cancer33–44. To this end, the human
OCT4 pseudogene OCT4-pg4 was demonstrated to sponge OCT4-
speciﬁc miRNAs in hepatocellular carcinoma cells45; human
OCT4-pg5 anti-sense transcripts reduce OCT4 promoter activity
and mouse OCT4-pg1 impacts on mesenchymal stem cell
differentiation via a still unknown mechanism39,46.
However, the role of Oct4 pseuodogenes in controlling mESC
pluripotency and self-renewal remains unknown.
Here we identify a panel of novel, processed murine Oct4
pseudogenes and report on a trans-epigenetic cross-talk
between an X-linked Oct4 pseudogene and the ancestral Oct4
gene, located on chromosome 17. We found that a long,
non-coding RNA transcribed in sense orientation from Oct4
pseudogene 4 (Oct4P4) recruits the H3K9-speciﬁc HMTase
SUV39H1 to induce epigenetic repression of the promoter of
the ancestral Oct4 gene in trans. This mechanism reduces the
expression of key self-renewal transcription factors and promotes
mESC differentiation. Importantly, functional disruption of
the Oct4P4–SUV39H1 silencing complex leads to a re-acquisition
of self-renewal features, such as Oct4 expression and the
re-activation of telomerase-dependent telomere maintenance
mechanisms. This indicates that Oct4P4 is essential to prevent
the re-activation of self-renewal circuits in differentiated cells.
Results
Oct4 pseudogenes expression during mESC differentiation.
Recent studies report the existence of eight OCT4 pseudogenes
in the human and one Oct4 pseudogene (Oct4-pg1, here
called ‘Oct4P1’) in the mouse genome36,38–40. Performing genome
blast analyses using the mouse Oct4 transcript 1 (Pou5f1)
complementary DNA (cDNA) as reference sequence, we
identiﬁed four additional candidate pseudogenes (Oct4P2,
Oct4P3, Oct4P4 and Oct4P5) that show high homology to
portions of the open reading frame and untranslated regions
(UTRs) of the ancestral Oct4 transcript 1 (Pou5f1) (Fig. 1a;
Supplementary Fig. 1a). Using primers speciﬁc for each Oct4
pseudogene, we were able to PCR amplify all candidate
pseudogenes from random or oligo-dT primed cDNA prepared
from mESC total RNA (Fig. 1b). No PCR product was obtained
when cDNA synthesis was carried out in the absence of primers
or reverse transcriptase, thus excluding RNA self-priming or
contamination of PCR reactions with genomic DNA. The identity
of all Oct4 pseudogene-derived RNAs was sequence validated
(Supplementary Fig. 1b). We conclude that Oct4P2, Oct4P3,
Oct4P4 and Oct4P5 represent novel, processed Oct4 pseudogenes
that are expressed in mESCs. Interestingly, Oct4P4 shows
homology to the entire mature Oct4 mRNA but has acquired a
334 bp insertion that shows high homology to the LTR element of
the ERVL-MaLRs retrotransposon family (Fig. 1a). Remarkably,
this insert is subjected to RNA splicing (Supplementary Fig. 1c).
To test whether Oct4 pseudogenes are subjected to transcriptional
regulation, we prepared total RNA from self-renewing mESC
(EB T0) and mESCs that were subjected to embryoid body (EB)
in vitro differentiation for 3 (EB D3), 5 (EB D5) or 7 (EB D7)
days (see Supplementary information). As expected, the ancestral
Oct4 gene is subjected to efﬁcient transcriptional repression
during 7 days of EB differentiation (Fig. 1c). We found that
EB differentiation is paralleled by a signiﬁcant reduction of
Oct4P1 and activation of Oct4P2 and Oct4P4 expression. EB
differentiation does not signiﬁcantly impact on Oct4P3 and
Oct4P5 expression (Fig. 1c). Remarkably, Oct4P4 long
non-coding RNA (lncRNA) levels are 150–300-fold higher in
primary mouse embryonic ﬁbroblasts (pMEFs) or immortalized
mouse embryonic ﬁbroblast compared with undifferentiated
mESCs (Fig. 1c). Considering the lower RNA content of
mESC compared with pMEFs47, we found that Oct4P4 lncRNA
levels are more than 600-fold higher in pMEFs compared with
mESCs (Supplementary Fig. 1e). Information on subcellular
localization of lncRNAs can provide important information about
a possible function as nuclear-restricted epigenetic regulator or
cytoplasmatic ceRNA27,48. Pseudogene-speciﬁc quantitative
reverse transcription–PCR (RT–PCR) using total RNA from
nuclear and cytoplasmatic fractions of undifferentiated mESCs
revealed that Oct4P2 and Oct4P4 are predominantly located in
the nucleus (Fig. 1d). Oct4P1, gapdh and the ancestral Oct4
mRNA show enrichment in the cytoplasm; Oct4P3 and Oct4P5
did not show speciﬁc enrichment in nucleus or cytoplasm
of mESCs (Fig. 1d). Together, these data indicate that a subset
of RNAs derived from Oct4 pseudogenes show controlled
intracellular localization and tight transcriptional regulation,
anticipating a potential role in the control of mESC
self-renewal. Unique properties of the Oct4P4 lncRNA such
as extended homology to the ancestral Oct4 gene, nuclear
localization, splicing, efﬁcient upregulation during mESC
differentiation and the virtual absence of relevant ORFs
(Supplementary Fig. 1d) prompted us to investigate a
possible role of Oct4P4 in the control of mESC differentiation
and self-renewal.
Oct4P4 lncRNA represses the expression of ancestral Oct4.
Next, we were interested in testing whether the existence of
Oct4P4 sense and anti-sense transcripts could provide a
possible inroad in understanding the role of Oct4P4 in mESC.
Performing sense/anti-sense-speciﬁc RT–PCR, we were not able
to detect anti-sense transcripts originating from the Oct4 and
Oct4P4 genes. We therefore concluded that a putative function of
Oct4P4 in mESCs must arise from Oct4P4 sense transcripts
(Supplementary Fig. 2a). Investigating a possible role for Oct4P4
in mESC biology, we stably overexpressed sense Oct4P4 lncRNA
in self-renewing mESCs. We found that stable overexpression
of Oct4P4 resulted in a 23% reduction of alkaline phosphatase
activity, a classic marker of mESC self-renewal potential
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Figure 1 | Characterization of murine Oct4 pseudogenes. (a) Schematic representation of Oct4 and Oct4 pseudogenes transcripts. Pseudogenes length
and percentage of sequence homology to Oct4 are indicated. Regions with high homology to the Oct4 50UTR or 30UTR are indicated by black boxes or
grey lines, respectively. ERVL-MaLRs, spliced region of Oct4P4 with homology to the LTR of ERVL-MaLRs retrotransposons. OCT4 protein domains are
indicated: N-terminal trans-activating domain (N-TAD), POU-speciﬁc DNA-binding domain (POUs), DNA-binding homeodomain (POUHD), C-terminal
trans-activating domain (C-TAD). (b) Veriﬁcation of Oct4 pseudogene expression in mouse embryonic stem cells (mESCs) by semi-quantitative PCR using
random primed (top panel) or oligo-dT primed (bottom panel) cDNA. RTþprimer, standard cDNA synthesis; no primer, cDNA synthesis without primers;
no RT, cDNA synthesis without reverse transcriptase. PCR products are visualized on a 1.2% agarose gel. (c) Oct4 lncRNA pseudogenes expression in
self-renewing mESCs (EB T0) and embryoid body (EB) aggregates at day 3 (EB D3), day 5 (EB D5) and day 7 (EB D7); pMEFs; immortalized pMEFs
and NIH-3T3 ﬁbroblasts. Oct4 pseudogenes expression was normalized to gapdh. ND, not detectable. (d) Subcellular localization of Oct4 pseudogene
lncRNA in self-renewing mESCs. Expression values are shown as percentage of total RNA expression. n, number of independent experiments; error bars
indicate s.d.; a Student’s t-test was used to calculate statistical signiﬁcance values: *Po0.05; **Po0.01; ***Po0.001.
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(Fig. 2a,b). Remarkably, Oct4P4 overexpression reduced AP
activity to a similar extent like RNA interference (RNAi)-
mediated depletion of endogenous Oct4 (Supplementary
Fig. 2b,c). Importantly, Oct4P4 overexpression caused a 50%
reduction of OCT4 protein levels (Fig. 2c). Reduced alkaline
phosphatase activity and OCT4 protein levels were found to be
paralleled by signiﬁcantly reduced mRNA expression of key
pluripotency transcription factors such as Oct4, Sox2, Klf4 and
Gdf3 and increased expression of early mESC differentiation
markers such as Fgf5, Brachyury, Nestin and Otx2 (Fig. 2d).
Together, this indicates that ectopic expression of Oct4P4 impairs
mESC self-renewal by interfering with transcriptional regulatory
circuits that control pluripotency.
To identify functionally relevant lncRNA domains, we created
a panel of Oct4P4 expression vectors lacking Oct4P4 sequence
elements with lowest sequence homology to the ancestral Oct4
cDNA (Fig. 2e). We found that stable overexpression of
Oct4P4D1 that lacks a 449 nucleotide region comprising the
334 bp ERVL-MaLRs retrotransposon homology sequence was
still able to reduce Oct4 mRNA and protein levels, recapitulating
the effect of full-length Oct4P4 (Fig. 2f). In contrast,
overexpression of Oct4P4D2, lacking sequences with high
homology to the Oct4 50 and 30 UTR regions were not able
to reduce Oct4 expression in mESCs (Fig. 2f). Oct4P4D1
overexpression signiﬁcantly reduces the expression of
pluripotency transcription factors. In contrast, Oct4P4D2
overexpression does not impact on self-renewing transcriptional
circuits in self-renewing mESCs (Fig. 2g). These data suggest that
Oct4P4 50 and 30UTR portions are important to reduce Oct4
expression. We therefore created additional Oct4P4 deletion
constructs centred on regions located at the 50 and 30 termini
of Oct4P4 lncRNA. Deleting the Oct4P4-50UTR (Oct4P4D50UTR)
or Oct4P4-30UTR (Oct4P4D30UTR) resulted a reduced efﬁciency
of Oct4 repression when compared with overexpression of
full-length Oct4P4 lncRNA (Supplementary Fig. 3a,b). Ectopic
expression of the 50UTR or 30UTR homology elements of the
Oct4P4 lncRNA (Oct4P4-50UTR or Oct4P4-30UTR, respectively)
did not impact on the expression of the ancestral Oct4 gene
(Supplementary Fig. 3c,d). Together these data indicate that the
50UTR and 30UTR homology region of Oct4P4 collaborate to
repress the expression of the ancestral Oct4 gene. Subcellular
fractionation experiments revealed that ectopic Oct4P4D1 RNA
maintains nuclear localization (Fig. 2h). In contrast, deletion of
both, 50 and 30 UTR homology regions resulted in a non-speciﬁc
subcellular distribution of Oct4P4D2 RNA in mESCs (Fig. 2h).
Finally, individually deleting the 50UTR or 30UTR homology
regions of Oct4P4 caused a reduced enrichment of
Oct4P4D50UTR or Oct4P4D30UTR RNAs in the nucleus
(Supplementary Fig. 3e). This indicates that the 50UTR or 30UTR
are important to mediate nuclear localization of Oct4P4. Of
note, overexpression of Oct4P4 did not cause a subcellular
de-localization of ancestral Oct4 or gapdh mRNAs, excluding
that Oct4P4 impairs mESC self-renewal by de-localizing the
ancestral Oct4 mRNA (Supplementary Fig. 3f). We conclude
that the Oct4P4 pseudogene gives rise to a sense lncRNA that
employs nuclear-restricted molecular mechanisms to reduce the
expression of pluripotency transcription factors, ﬁnally leading to
impaired mESC self-renewal.
Oct4P4 lncRNA orchestrates silencing of the Oct4 promoter.
Based on the fact that nuclear localization is essential for Oct4P4
lncRNA function, we speculated that Oct4P4 might directly
interact with the promoter of the ancestral Oct4 gene. To test this
hypothesis, we performed Oct4 promoter luciferase reporter
experiments in NIH-3T3 cells that lack expression of endogenous
Oct4 (Fig. 1c, Fig. 3a). Co-transfection of the reporter with a
plasmid-encoding haemagglutanin (HA)-epitope-tagged murine
OCT4 under the control of the CMV promoter was able to
increase Oct4 promoter luciferase reporter activity (Fig. 3b,
left panel). Importantly, Oct4P4 overexpression signiﬁcantly
attenuated this effect without affecting expression levels of
ectopically expressed OCT4 protein (Fig. 3b, right panel). This
suggests that Oct4P4-derived lncRNAs speciﬁcally reduced the
activity of the Oct4 promoter used in the reporter construct.
To provide evidence for a cross-talk between Oct4P4 ncRNA and
the promoter of the ancestral Oct4 gene in trans, we established
an ‘Oct4P4-MS2 RNA stem loop’ tethering system in mESC49.
We generated mESCs stably co-expressing a ﬂag-tagged version
of MS2 phage coat protein (MS2-ﬂag), as well as Oct4P4 lncRNA
fused to 24 repeats of the MS2 RNA stem loop (24MS2
stem loop), that binds with high afﬁnity to MS2 phage coat
protein (Fig. 3c; Supplementary Material and Methods). This
model system permits the use of anti-ﬂag antibodies to detect
Oct4P4-24MS2 stem loop RNA at gene loci by chromatin
immunoprecipitation (ChIP) or to identify Oct4P4 interacting
proteins by RNA immunoprecipitation (RIP) (Fig. 3c). mESCs
exclusively overexpressing MS2-ﬂag were used as a control cells.
In line with previous data, overexpression of MS2 stem
loop-tagged Oct4P4 (Oct4P4-24MS2 stem loop) results in
reduced OCT4 protein and mRNA expression (Fig. 3d).
Importantly, we were able to efﬁciently amplify Oct4P4-
24MS2 stem loop RNA by RT–PCR in anti-ﬂag RIP
experiments using mESCs stably co-expressing MS2-ﬂag and
Oct4P4-24MS2 stem loop constructs. This demonstrates that
MS2-ﬂag forms a complex with the Oct4P4-24MS2 stem loop
RNA in vivo (Fig. 3e). To demonstrate that Oct4P4-24MS2
stem loop RNA localizes to the endogenous Oct4 promoter region
in MS2-ﬂag expressing mESCs, we performed ChIP experiments
using a set of primer pairs that speciﬁcally amplify the promoter
of the ancestral Oct4 gene (Fig. 3a; primer pairs A, B)50.
Performing ChIP using anti-ﬂag antibodies, we were able to
demonstrate the presence of MS2-Flag at the conserved Oct4
promoter/enhancer region CR2 in MS2-ﬂag/Oct4P4-24MS2
stem loop RNA-expressing mESCs (Fig. 3f). Importantly,
MS2-ﬂag control mESCs that lack Oct4P4-24MS2 stem
loop RNA expression did not show association of MS2-ﬂag
with the Oct4 promoter (Fig. 3f). Anti-ﬂag ChIP did not
immunoprecipitate the promoter region of the unrelated Dkk
gene in control cells (Fig. 3f, right panel).
Together, our data demonstrate that the Oct4P4 lncRNA is
required to localize MS2-ﬂag to the Oct4 promoter in MS2-ﬂag/
Oct4P4-24MS2 stem loop RNA-expressing mESCs. This data
support a model where a sense-oriented Oct4P4 lncRNA can
localize in trans to the promoter of the Oct4 gene.
Nuclear, lncRNAs such as XIST, HOTAIR or pericentric
satellite repeats plays a key role in recruiting epigenetic repressors
such as the H3K9-speciﬁc SUV39H Histone HMTases or
H3K27-speciﬁc HMTase containing Polycomb repressive
complexes51–53. We consequently speculated that upregulation
of Oct4P4 ncRNA expression during mESC differentiation
(Fig. 1c) might direct epigenetic silencing complexes to the
endogenous Oct4 promoter. Taking advantage of our Oct4P4-
MS2 RNA tethering mESC model system, we found that Oct4P4-
24MS2 stem loop RNA overexpression in MS2-ﬂag mESCs
result in a ﬁvefold increase of H3K9me3 at conserved Oct4
promoter/enhancer regions (CR1, CR2; detected by primer pairs
A and B), as determined by ChIP (Fig. 3a,g). Consistent with the
reported high binding afﬁnity of HP1 to H3K9me3 (ref. 54), we
found a sixfold increase of HP1a at the Oct4 promoter in our
model mESC line (Fig. 3g). Of note, Oct4P4-24MS2 stem loop
RNA overexpression in MS2-ﬂag mESCs does not impact on the
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Figure 2 | Oct4P4 impairs mESC self-renewal potential. (a) Quantitative real-time PCR determining Oct4P4 lncRNA expression levels in mESCs stably
overexpressing Oct4P4. Oct4P4 expression was normalized to gapdh. (b) Spectrophotometric measurement of alkaline phosphatase (AP) activity in mESC
stably overexpressing Oct4P4. (c) Ectopic Oct4P4 expression in self-renewing mESC reduces the expression of Oct4 as determined by quantitative real-time
PCR (left panel) or OCT4 western blotting (right panel). Expression values were normalized against gapdh; ACTIN was used as a loading control in western
blotting experiments. Numbers represent OCT4/ACTIN ratios (d) Quantitative real-time PCR analysis of self-renewal marker genes (left panel) or markers of
early mESC differentiation (right panel) in mESCs stably overexpressing Oct4P4. Expression levels were normalized against Gapdh. (e) Schematic
representation of full-length and Oct4P4 deletion constructs. Oct4P4D1 lacks intronic ERVL-MaLR homology region and ﬂanking sequences. Oct4P4D2 carries
a 60 nt and 76 nt deletion at the 50 and 30 end of full-length Oct4P4, respectively. (f) Quantitative real-time PCR analysis using mESCs stably overexpressing
Oct4P4, Oct4P4D1 and Oct4P4D2. Expression values were normalized against gapdh (left panel). OCT4 western blotting analysis in mESCs stably
overexpressing Oct4P4, Oct4P4D1 or Oct4P4D2. ACTIN was used as a loading control (right panel). Oct4P4D2 does not alter Oct4 expression. (g) Expression
of pluripotency marker genes in mESCs ectopically expressing Oct4P4, Oct4P4D1 or Oct4P4D2, as determined by quantitative real-time PCR analysis.
Expression values were normalized against gapdh. (h) Subcellular localization of Oct4P4, Oct4P4D1 and Oct4P4D2 in mESCs stably expressing the indicated
construct, as determined by real-time PCR. Expression values are shown as percentage of total expression. n, number of independent experiments carried out;
error bars indicate s.d.; ND; not detected; a Student’s t-test was used to calculate statistical signiﬁcance values: *Po0.05; **Po0.01; ***Po0.001.
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abundance of H4K20me3 or H3K27me3 at the Oct4 promoter
(Fig. 3g). In line with increased H3K9me3 levels, we found a
fourfold increase of the H3K9-speciﬁc SUV39H1 HMTase at the
Oct4 promoter of MS2-ﬂag/Oct4P4-MS2-24MS2 stem loop
mESCs (Fig. 3h). To individuate Oct4P4 lncRNA regions that are
important for SUV39H1 interaction and SUV39H1 deposition on
the Oct4 promoter, we performed anti-SUV39H1 ChIP and RIP
experiments using mESCs stably overexpressing full-length
Oct4P4, Oct4P4D50UTR, Oct4P4D30UTR or Oct4P4D2 lncRNAs.
Importantly, we found that SUV39H1 deposition on the Oct4
promoter was reduced in Oct4P4D50UTR and Oct4P4D30UTR
cells when compared with full-length Oct4P4 overexpressing cells
(Supplementary Fig. 4a). Deletion of the Oct4 50 and 30 UTR
homology regions in Oct4P4 reduced efﬁciency of Oct4P4
lncRNA mediated repression of Oct4 (Fig. 2f). In line with this,
mESCs overexpressing Oct4P4 lncRNAs lacking the 50UTR
(Oct4P4D50UTR) or 30UTR (Oct4P4D30UTR) homology show
reduced SUV39H1 abundance at the Oct4 promoter when
compared with cells overexpressing the full-length Oct4P4
lncRNA (Supplementary Fig. 4a). Finally, overexpression of an
Oct4P4 version lacking both the 30 and 50 UTR homology region
(Oct4P4D2) did not result in the accumulation of SUV39H1 at
the Oct4 promoter. This indicates that the 50 and 30UTR
homology regions are important to localize SUV39H1 to the
Oct4 promoter. Accordingly, Oct4P4D2 was no longer able to
physically interact with SUV39H1 (Supplementary Fig. 4b),
further underlying the importance of 50 UTR and 30UTR
homology regions for Oct4P4 function.
Altogether, our data show that the Oct4P4 lncRNA, expressed
in sense orientation from X-linked Oct4P4 locus, mediates the
enrichment of H3K9me3, HP1a and SUV39H1 at the Oct4
promoter, located on chromosome 17. This trans-acting silencing
mechanism leads to reduced Oct4 expression that ﬁnally results
in impaired self-renewal potential of mESCs (Fig. 3d,g,h).
An Oct4P4–SUV39H1 complex targets the Oct4 promoter. We
showed that Oct4P4 lncRNA overexpression leads to chromatin
compaction at the promoter of the ancestral Oct4 gene. We next
wished to test whether (i) Oct4P4 physically interacts with
SUV39H1 and (ii) both players are required to induce epigenetic
gene silencing at the promoter of the ancestral Oct4 gene.
Using MS2-ﬂag/Oct4P4-24MS2 stem loop model mESC, we
found that anti-SUV39H1-speciﬁc antibodies were able
to immunoprecipitate MS2-ﬂag but also Oct4P4-24MS2
stem loop lncRNA (Fig. 4a; Supplementary Fig. 5a). Importantly,
also endogenous Oct4P4 lncRNA was detectable by RT–PCR in
anti-SUV39H1 RIP experiments using pMEFs, that are
characterized by high Oct4P4 lncRNA expression levels (Figs 1c
and 4b). Of note, Oct4P4 lncRNA abundance was found to be
strongly reduced in anti-SUV39H1 RNA immunoprecipitates
after RNAi-mediated reduction of endogenous Oct4P4, thus
conﬁrming the speciﬁcity of our experiments (Fig. 4b).
Next, we wished to validate that SUV39H1 is required to
reduce Oct4 expression by mediating the enrichment of
H3K9me3 and its high-afﬁnity binding partner HP1a at the
Oct4 promoter.
RNAi-mediated knockdown of SUV39H1 resulted in
signiﬁcantly increased Oct4 mRNA and OCT4 protein levels in
wild-type mESCs and Oct4P4 lncRNA-overexpressing mESCs.
This provided ﬁrst evidence that the SUV39H1 HMTase
controls Oct4 expression in mESCs (Fig. 4c,d). To understand
the relevance of SUV39H1 for the establishment of a repressive
chromatin structure at the endogenous Oct4 promoter,
we performed anti-ﬂag and anti-SUV39H1 ChIP experiments in
MS2-ﬂag/Oct4P4-24MS2 stem loop mESCs. As expected,
SUV39H1 RNAi resulted in reduced abundance of
SUV39H1 and H3K9me3 at the Oct4 promoter in MS2-ﬂag/
Oct4P4-24MS2 stem loop mESCs (Fig. 4e, Supplementary
Fig. 5b). Importantly, this effect was paralleled by reduced
MS2-ﬂag levels at the Oct4 promoter, indicative for reduced
abundance of Oct4P4-24MS2 stem loop RNA at the ancestral
Oct4 promoter. Together, this indicates that both SUV39H1 and
Oct4P4 lncRNA are required to mediate localization of the
silencing complex to the endogenous Oct4 promoter.
Oct4P4 blocks aberrant acquisition of self-renewal features.
High Oct4P4 lncRNA expression levels in pMEFs (Fig. 1c)
suggest that the Oct4P4–SUV39H1 lncRNA–protein complex
has an important role in silencing the endogenous Oct4 promoter
in differentiated cells. In line with this hypothesis, we found
that siRNA-mediated knockdown of Oct4P4 lncRNA in pMEFs
results in a fourfold or twofold reduction of SUV39H1
or H3K9me3 at the Oct4 promoter, respectively (Fig. 5a,b).
Importantly, reduced chromatin compaction at the Oct4
promoter was paralleled by a signiﬁcant increase in Oct4 mRNA
expression (Fig. 5c). This data was conﬁrmed in experiments
using an independent Oct4P4 lncRNA-speciﬁc siRNA
oligonucleotide (Supplementary Fig. 6a,b). This indicates that
the Oct4P4–SUV39H1 complex plays an important role in
maintaining silencing of the Oct4 promoter in pMEFs.
Interestingly, we found that Oct4P4 is efﬁciently repressed during
the conversion of pMEFs to iPS (Fig. 5d). This suggests that
Figure 3 | Oct4P4 mediates the imposition of H3K9me3 and HP1a at the Oct4 gene. (a) Schematic representation of the mouse Oct4 promoter region
showing the location of the speciﬁc distal enhancer (DE), proximal enhancer (PE), proximal promoter (PP) sites and the conserved promoter/enhancer
regions (CR1, CR2). The locations of PCR amplicons (A and B) used in ChIP experiments are indicated. (b) Luciferase reporter assay demonstrating that
Oct4P4 controls Oct4 promoter activity. NIH-3T3 cells were co-transfected with indicated vectors. Luciferase activity was assayed 72 h after co-transfection
(left panel); western blotting experiments using the indicated antibodies were performed in parallel (right panel). (c) Schematic representation of the
Oct4P4-24MS2 stem loop construct used to generate mESCs stably expressing MS2-ﬂag and Oct4P4-24MS2 stem loop RNA. (d) Oct4P4-24MS2
stem loop RNA overexpression in mESC reduces the expression of ancestral Oct4, as determined by quantitative RT–PCR; expression values were
normalized against Gapdh (top panel); Result was validated by OCT4 western blotting, using ACTIN as a loading control (bottom panel). (e) RIP using
mESCs overexpressing MS2-ﬂag/Oct4P4-24 MS2 stem loop RNA or MS2-ﬂag control cells. Agarose gel electrophoresis after semi-quantitative PCR
demonstrates the presence of Oct4P4-24MS2 stem loop RNA in anti-ﬂag RIP experiments (top panel). Immunoprecipitation of MS2-ﬂag was validated
by western blotting (bottom panel) (f) ChIP using speciﬁc anti-ﬂag antibodies followed by quantitative RT–PCR using lysates from MS2-ﬂag/Oct4P4-
24MS2 stem loop or MS2-ﬂag control mESCs. MS2-ﬂag is enriched at the Oct4 promoter in Oct4P4-24MS2 stem loop mESCs (left panel); no
enrichment was detected at the unrelated Dkk promoter (right panel). ChIP data were quantiﬁed versus input and unrelated HA-speciﬁc antibodies.
(g) ChIP analysis of Oct4 promoter region in mESCs stably overexpressing Oct4P4 using indicated antibodies. Quantitative RT–PCR was performed to
measure promoter enrichment. Oct4P4 overexpression drives H3K9me3 and HP1a enrichment at Oct4 promoter region. (h) ChIP analysis of Oct4 promoter
region in MS2-ﬂag/Oct4P4-24MS2 stem loop and control MS2-ﬂag mESCs using SUV39H1-speciﬁc antibodies. Oct4P4-24MS2 stem loop results in
an enrichment of SUV39H1 at the Oct4 promoter. n, number of independent experiments carried out; WB, western blotting; error bars indicate s.d.;
a Student’s t-test was used to calculate statistical signiﬁcance values: *Po0.05; **Po0.01; ***Po0.001.
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Oct4P4 might represent a barrier to the de-differentiation of
pMEFs. To further test this idea, we performed Oct4P4 loss-of-
function experiments in pMEFs. Oct4P4 knockdown caused a
change of the characteristic ﬂat and single-cell morphology of
pMEFs to round-shaped cells but also the formation of multi-
cellular spheres that grow in suspension or attached on top of
pMEFs (Fig. 5e). The formation of spheres or round-shaped
cells was inhibited when pMEFs were co-transfected with a mix
of siOct4P4 and siOct4 oligonucleotides, indicating that changes
in cell morphology are Oct4 dependent (Fig. 5e,f). Importantly,
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siOct4P4-induced changes in cell morphology were paralleled by
a signiﬁcantly increased expression of mESC pluripotency tran-
scription factors Oct4 (threefold), Sox2 (threefold), Nanog
(threefold) and Klf4 (twofold) (Fig. 5f). This data was conﬁrmed
in experiments using an independent Oct4P4-speciﬁc siRNA
oligonucleotide (Supplementary Fig. 6c). Remarkably, siOct4P4-
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Figure 4 | Oct4P4 interacts with SUV39H1 to silence ancestral Oct4 in trans. (a) Anti-SUV39H1 RIP using MS2-ﬂag/Oct4P4-24MS2 stem loop
mESCs or MS2-ﬂag mESCs cells. Efﬁciency of anti-SUV39H1 immunoprecipitation was validated by western blotting (top panel). SUV39H1 is not
detectable in inputs due to reduced antibody efﬁciency in western blotting compared with immunoprecipitation (Supplementary Fig. 5a). MS2-ﬂag
co-immunoprecipitates with SUV39H1 only in the presence of Oct4P4-24MS2 stem loop RNA, as determined by western blotting (middle panel).
Semi-quantitative RT–PCR followed by agarose gel electrophoresis veriﬁed the presence of Oct4P4-24MS2-stem loop RNA in anti-SUV39H1 RIP (bottom
panel). (b) Anti-SUV39H1 RIP immunoprecipitation of endogenous Oct4P4 RNA from lysates obtained from pMEFs transfected with control or Suv39h1-
speciﬁc siRNAs. Efﬁciency of SUV39H1 immunoprecipitation was validated by western blotting (top panel). Oct4P4 RNA is undetectable in RIP experiments
using lysates from Suv39h1 depleted cells, demonstrating the speciﬁcity of the anti-SUV39H1 antibody (bottom panel). A human inﬂuenza haemagglutinin
(HA) antibody was used as a control in RIP experiments. (c,d) Oct4 expression levels in wild-type (wt) mESCs and mESCs stably overexpressing Oct4P4
after transient transfected with the indicated siRNA oligos. Suv39h1 knockdown increases Oct4 expression on the protein (c) and mRNA level (d) as
determined by western blotting (c) and quantitative real-time PCR (d). ACTIN was used as a loading control in western blotting; Oct4 mRNA levels were
normalized to gapdh. (e) Oct4 promoter ChIP using MS2-ﬂag control and MS2-ﬂag/Oct4P4-24MS2 stem loop mESCs under Suv39h1 knock-down
conditions. Quantitative real-time PCR on anti-ﬂag immunoprecipitates demonstrates that a Oct4P4-24MS2 stem loop/MS2-ﬂag RNA–protein complex
associates with the endogenous Oct4 promoter only in the presence of Suv39h1 (left panel). Suv39h1 knockdown signiﬁcantly reduces SUV39H1 abundance
at the Oct4 promoter, demonstrating speciﬁcity of the anti-SUV39H1 antibody (middle panel). An HA antibody was used as a control (right panel).
Dkk promoter was used as a negative control. n, number of independent experiments carried out; WB, western blotting; error bars indicate s.d.; a Student’s
t-test was used to calculate statistical signiﬁcance values: *Po0.05; **Po0.01; ***Po0.001.
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Figure 5 | Oct4P4 prevents the activation of features of mESC self-renewal in pMEFs. (a) Quantitative real-time PCR determining Oct4P4 expression
levels in pMEFs transiently transfected with siRNA targeting Oct4P4. Control cells were transfected with siRNA control oligos. Oct4P4 expression was
normalized to gapdh. (b) Oct4 promoter ChIP analysis using SUV39H1- or H3K9me3-speciﬁc antibodies in MEFs transiently transfected with indicated
siRNAs. Oct4P4 siRNA reduces H3K9me3 and SUV39H1 abundance, at the Oct4 promoter, as determined by quantitative real-time PCR (Oct4 amplicon A).
Dkk promoter was used as a negative control. (c) siRNA-mediated knockdown of Oct4P4 in pMEFs increases Oct4 expression in quantitative real-time PCR
experiments. Expression values were normalized against gapdh. (d) Oct4P4 lncRNA expression in pMEFs and their derivative iPS cells. mESCs were included
as control. Oct4P4 expression levels were normalized against gapdh. (e) Morphology of pMEFs transfected with the indicated siRNAs oligonucleotides. Black
arrows indicate cells with altered cell morphology. White arrows indicate pMEFs. Scale bar, 100mm (f) Quantitative real-time PCR analysis of Oct4P4 lncRNA
levels (left panel) and mESC self-renewal marker genes (right panel) in pMEFs transiently transfected with siRNA targeting Oct4P4 or with a combination of
siOct4P4 and siOct4 oligonucleotides. Expression levels were normalized against gapdh. Knockdown of Oct4P4 causes an increased expression of self-renewal
marker genes. Reduction of Oct4 expression in the context of Oct4P4 knockdown rescues self-renewal marker genes. (g) TertmRNA expression level in pMEFs
transfected with indicated siRNA oligonucleotides, as determined by quantitative real-time PCR. siRNA-mediated knockdown of Oct4P4 increases Tert
expression. Expression levels were normalized against gapdh. (h) Measurement of telomere repeat content by quantitative real-time PCR. Total genomic DNA
from pMEF transiently transfected with indicated siRNA oligonucleotides were analysed using telomere repeat-speciﬁc PCR primers (right panel). Alu-
equivalent B1 repeats were used as a reference sequence. siRNA-mediated reduction of Oct4P4 leads to increased telomere repeat content, indicative for
increased telomere length. Knock-down efﬁciency was validated by quantitative RT–PCR (left panel). n, the number of independent experiments carried out;
error bars indicate s.d.; a Student’s t-test was used to calculate statistical signiﬁcance values: *Po0.05; **Po0.01; ***Po0.001.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms8631 ARTICLE
NATURE COMMUNICATIONS | 6:7631 | DOI: 10.1038/ncomms8631 | www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
dependent increase of pluripotency transcription factor expres-
sion was attenuated by contemporary knockdown of Oct4
(Fig. 5f). Together, this indicates that depletion of Oct4P4 from
pMEFs results in a loss of heterochromatin at the Oct4 promoter,
leading to the re-activation of endogenous Oct4 that promotes the
expression of additional key transcription factors of mESC self-
renewal. To ﬁnd evidence that loss of Oct4P4 activates other
biological pathways linked to mESC self-renewal programmes, we
studied the impact of Oct4P4 on telomere maintenance in pMEFs.
pMEFs are characterized by progressive telomere shortening
due to lack of sufﬁcient telomerase activity. In line with this,
re-activation of telomerase activity is a key step for the acquisition
of pluripotency during iPS reprogramming of pMEFs55.
Importantly, we found that 2 consecutive cycles of RNAi-
mediated depletion of Oct4P4 from pMEFs resulted in a 2.6-fold
upregulation of the transcript for the catalytic subunit of
telomerase, TERT. Importantly, Tert mRNA upregulation was
paralleled by a concomitant increase in telomeric DNA repeat
content, as determined by real-time PCR-based quantiﬁcation of
telomeric DNA repeats in experimental cells (Fig. 5g,h). This data
was conﬁrmed in experiments using independent Oct4P4-speciﬁc
siRNA oligonucleotides (Supplementary Fig. 6c,d). This indicates
that Oct4P4 depletion re-activates telomerase expression to drive
telomere elongation. Remarkably, these effects were attenuated
when pMEFs where transfected with a mix of siRNAs that target
Oct4P4 lncRNA and the ancestral Oct4 mRNA (Fig. 5g,h).
Together, our data demonstrate that depleting Oct4P4 from
differentiated pMEFs results in the re-activation of basic features
of mESC pluripotency, such as self-renewal transcription factor
expression and activation of telomerase-dependent mechanisms
of telomere maintenance. This further indicates that Oct4P4 has
an important role in preventing the aberrant expression of self-
renewal promoting transcription factors in differentiated cells.
Discussion
Pseudogene-derived transcripts have been reported to impact on
the expression of ancestral protein-coding gene using molecular
pathways based on RNA sequence homology. Pseudogenes
derived transcripts were demonstrated to control ancestral gene
by producing endogenous siRNAs, sponging miRNAs by acting
as ceRNAs or altering the stability of the ancestral mRNA28–32,56.
In addition, anti-sense pseudogene transcripts can impact on the
promoter activity of ancestral genes30,36,57,58. In this study, we
used mESCs to identify a set of novel transcripts derived from
putative Oct4 pseudogenes (Oct4P1, Oct4P2, Oct4P3 Oct4P4 and
Oct4P5). Tight regulation of subcellular localization and
expression during mESC differentiation anticipate a deﬁned
role for a subset of these transcripts in mESC biology. Here we
focused our studies on a nuclear-restricted non-coding RNA
(ncRNA) that is transcribed in sense orientation from the
processed, X-linked Oct4P4. Dramatic upregulation of sense
Oct4P4 transcription during mESC differentiation gives rise to a
long, non-coding RNA that forms a complex with the repressive
H3K9-speciﬁc HMTase SUV39H1. This complex translocates to
the promoter of the ancestral Oct4 protein-coding gene, located
on chromosome 17, to impose H3K9 tri-methylation leading to a
consecutive recruitment of HP1a and silencing of the ancestral
Oct4 gene (Fig. 6). This is in a remarkable contrast to the ceRNA
function of the human cytoplasmatic lncRNA OCT4-pg4 in
hepatocellular carcinoma45. Thus murine Oct4P4 and human
OCT4-pg4 are not mechanistically conserved and act via
completely different cellular pathways. A recent study reported
that anti-sense transcripts originating from the human OCT4-pg5
can mediate silencing of the human OCT4 gene in cancer cells46.
Importantly, we were not able to detect anti-sense transcripts
originating from murine ancestral Oct4 or Oct4P4 genes
(Supplementary Fig. 2a). We also did not ﬁnd a signiﬁcant
homology between the Oct4P4 lncRNA and the Oct4 promoter
(Supplementary Fig. 7c). Finally, Oct4P4 lncRNA did not impact
on Oct4P4 promoter activity (Supplementary Fig. 7a,b). Thus,
these ﬁndings do not support a model that involves the
expression of an anti-sense Oct4P4 transcript or direct
interaction of Oct4P4 lncRNA with the Oct4 promoter that is
based on sequence homology. We rather propose that sense-
oriented Oct4P4 lncRNAs represents the functionally relevant
pseudogene-derived lncRNA that forms a complex with
SUV39H1 and then translocates to the promoter of the
ancestral Oct4 gene. In line with this, deleting Oct4P4 50 or 30
sequences that show high homology to the 50UTR or 30UTR
regions, respectively, of ancestral Oct4 signiﬁcantly reduce the
ability of Oct4P4 lncRNA to deposit SUV39H1 at the Oct4
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Figure 6 | A model for Oct4P4 lncRNA function. The nuclear, long non-coding Oct4P4 is upregulated during mESC differentiation and recruits the H3K9-
speciﬁc HMTase SUV39H1 to impose H3K9me3 and HP1a at the promoter of ancestral Oct4 gene in trans, leading to Oct4 gene silencing. Depletion of
Oct4P4 lncRNA in differentiated pMEFs results in re-activation of Oct4 expression and the acquisition of classic features of self-renewal such as increased
expression of self-renewal transcription factors and activation of telomerase-dependent telomere maintenance mechanisms. This indicates that Oct4P4
prevents the aberrant expression of self-renewal programmes in differentiated cells.
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promoter, thus leading to reduced Oct4 silencing. This highlights
a possible importance of 50UTR and 30UTR homology regions of
pseudogene-derived sense transcripts for epigenetic gene
regulation.
Remarkably, the human OCT4-pg3 (here OCT4P3,
NR_036440.1), OCT4-pg4 (here OCT4P4, NR_034180.1) and
OCT4-pg1 (here OCT4P1b NM_001159542.1) show homology to
the entire OCT4 cDNA and share high structural and sequence
homology to murine Oct4P4. Similar to Oct4P4 in mESCs, we
found that human OCT4P3 lncRNA is enriched in the nuclei of
OVCAR-3 and SKOV-3 ovarian cancer cells (Supplementary
Fig. 8). This provides a ﬁrst indication for a possible conservation
of Oct4P4/OCT4P3 function.
Interfering with the murine Oct4P4–SUV39H1 silencing
complex in differentiated cells leads to the re-activation of mESC
self-renewal transcription factor expression and telomerase-
dependent telomere maintenance mechanism (Fig. 6). This
represents a partial re-acqusition of mESC stem cell features in
short term (6 days) Oct4P4 lncRNA knock-down experiments. It
will be interesting to test whether loss of Oct4P4 function can
increase the efﬁciency of iPS cell generation protocols. Together,
our data indicates that Oct4P4 and SUV39H1 are important to
prevent the aberrant activation of mESCs self-renewal pathways
in differentiated cells. Future experiments will aim to better deﬁne
structural Oct4P4 lncRNA motifs involved in SUV39H1 recruit-
ment and elucidate pathways that direct Oct4P4 to the ancestral
Oct4 gene.
Several lncRNAs such as XIST or HOTAIR have been described
to act as scaffold for the formation of chromatin-modifying
complexes51,52. To our knowledge, the Oct4P4 lncRNA represents
the ﬁrst example for a crucial role of a vertebrate pseudogene-
derived sense lncRNAs in directing chromatin-modifying
activities to the promoter of its ancestral gene in trans.
Given the vast repertoire of vertebrate pseudogenes, we
anticipate the existence of a series of pseudogene-derived
lncRNAs that use mechanisms analogous to Oct4P4 to control
the expression of ancestral genes on the epigenetic level.
Understanding pseudogene lncRNA-dependent mechanism of
epigenetic gene regulation and a precise categorization of
pseudogene-derived lncRNAs based on subcellular localization,
gene expression regulation and deposition at gene promoters will
provide important insights into the global role of pseudogene-
derived lncRNAs in regulating higher order chromatin structures.
Methods
Cell culture and generation of stable cell lines. Feeder-independent mouse
ESCs59 were cultured on gelatin (0.2%) coated plates in mESC self-renewal
medium (DMEM with 15% knockout serum replacement (Gibco), 1% nonessential
amino acids (Gibco), 1mM sodium pyruvate (Invitrogen), 1% L-glutamine
(Invitrogen), 0.1mM -mercaptoethanol, 1% penicillin/streptomycin (Invitrogen)
and 1,000Uml 1 mouse leukaemia inhibitory factor. pMEFs were generated from
13.5 d.p.c C57BL/6 mouse embryos. NIH-3T3 cells were obtained from ATCC.
pMEFs and NIH-3T3 cells were maintained in culture in DMEM supplemented
with 10% foetal bovine serum (Lonza) and 1% penicillin/streptomycin. iPS were
generated and cultivated according to standard conditions60. OVCAR-3 cells
(ATCC) were cultured in RPMI-1640 medium supplemented with 20% foetal
bovine serum (Lonza), L-glutamine (2mM), insulin (10 mgml 1; I9278, Sigma)
and 1% penicillin/streptomycin. SKOV-3 cells (ATCC) and U2OS cells (ATCC)
were maintained in DMEM supplemented with 10% foetal bovine serum and 1%
penicillin/streptomycin. To generate stable mESC lines, cells were transfected
(TransIT-LT1; Mirus Bio LCC) with respective vectors and subjected to selection
using G418 (Sigma, 300mg ml 1) or puromycin (Sigma, 3 mgml 1).
Oct4 pseudogenes analysis and sequencing. Genome blast analysis (http://
blast.ncbi.nlm.nih.gov/) was performed to identify mouse genomic regions with
high similarity to Oct4 (mus musculus Pou5f1, transcript variant 1; NM_013633.3)
mRNA. Genomic coordinates of identiﬁed pseudogenes were obtained using the
University of California Santa Cruz (UCSC) genome browser. All candidate
pseudogenes were PCR ampliﬁed from mESC cDNA using speciﬁc primers
(Supplementary table 1). PCR amplicons were cloned into pCR2.1-TOPO vector
(Life Technologies) and subjected to bi-directional sequencing.
Oct4P4-MS2 tethering model system. To generate the Oct4P4-24MS2 stem
loop construct, 24 repeats of the MS2 stem loop RNA motif (obtained from
pSL-MS2-24 , ref. 61) were cloned downstream of the Oct4P4 cDNA into pLPC.
Oct4P4 cDNA was PCR ampliﬁed using the following oligonucleotides: forward:
50-GGGAATTCAAGCTTGTCCCTAGGTGACCAACTCCT30-; reverse: 50-GGGA
ATTCAGATCTTGTGTCCCAGGCTTTTTAAA30-). pCMV-FLAG-MS2nls was
provided by A. Marcello (ICGEB, Trieste, Italy).
RNA immunoprecipitation. Cells were cross-linked in culture medium with 1%
formaldehyde for 10min. After addition of 125mM glycine (PBS), cells were
washed twice in ice cold PBS. Cross-linked cells were scraped in RIPA buffer
(50mM Tris-Cl, pH 7.5, 1% Nonidet P-40 (NP-40), 0.5% sodium deoxycholate,
0.05% SDS, 1mM EDTA,150mM NaCl) and supplemented with protease
inhibitors (Complete, Roche) and RNaseOUT (Invitrogen). After incubation at
4 C for 20min, the cell lysate was sonicated and centrifuged. The supernatant was
pre-cleared for 1 h at 4 C with protein A/G PLUS-Agarose (sc-2003; Santa Cruz
Biotechnology), supplemented with yeast transfer RNA (0.1mgml 1, Invitrogen)
and incubated overnight at 4 C with the following antibodies: mouse monoclonal
anti-FLAG M2, clone M2 (2.5 mgml 1; F1804; Sigma); mouse monoclonal anti-
KMT1A/SUV39H1 (2.5mgml 1; ab12405; Abcam); mouse monoclonal anti-HA,
(2.5 mgml 1; clone HA-7, H9658; Sigma). RNA–protein complexes were recov-
ered with protein A/G PLUS-Agarose beads and were washed six times in
high-stringency RIPA buffer (50mM Tris-Cl, pH 7.5, 1% sodium deoxycholate,
0.1% SDS, 1mM EDTA, 1M NaCl, 1M urea and 0.2mM phenylmethylsulfonyl
ﬂuoride). An aliquot of beads containing immunoprecipitatated samples were
saved for western blot analysis. Remaining beads were resuspended in 50mM
Tris-Cl, pH 7.0, 5mM EDTA, 10mM DTT and 1% SDS and incubated at 70 C for
45min to reverse cross-linking. The immunoprecipitated RNA and the total RNA
were extracted with the Qiazol lysis reagent (Qiagen), subjected to DNase
treatment (Qiagen) and subjected to reverse transcription (Quantitect reverse
transcription kit; Qiagen). The obtained cDNA used for quantitative real-time PCR
(SYBR Green Universal PCR Master Mix, Applied Biosystems) on a StepOnePlus
real-time PCR machine (Applied Biosystems). The oligos used for quantitative
RT–PCR are reported below:
Oct4P4: forward: 50-TGGCACCTGGCTTTAGACTTT-30; reverse: 50-CCAGG
CCAACTTAGGGCATT-30 . 24MS2-Oct4P4: forward: 50-CACCACGGCT
TTGGAGTTAAG-30; reverse: 50-CATTAGATCTTGTGTCCCAG-30 .
Analysis of immunocomplexes by western blotting: input and
immunocomplexes proteins were resuspended in SDS–PAGE sample buffer,
boiled for 15min and analysed by western blotting. Primary antibodies: mouse
monoclonal anti-FLAG (1:1,000; clone M2, F1804); mouse monoclonal
anti-KMT1A/SUV39H1 (1:500; ab12405); mouse monoclonal anti-HA, clone
(1:1,000; HA-7, H9658) rabbit polyclonal anti-Oct4 (1:1,000; ab19857; Abcam);
anti-actin (1:1,000; A2066; Sigma). Secondary antibodies coupled to horseradish
peroxidase (1:1,000; A-6154; A-4416; Sigma) were used for signal detection.
Chromatin immunoprecipitation. Cells were cross-linked in culture medium with
1% formaldehyde for 10min, neutralized using 125mM glycine in PBS and
washed in PBS. Nuclei were obtained by lysing scraped cells in hypotonic buffer
(5mM Pipes pH 6.8, 85mM KCl, 0.5% NP-40 and protease inhibitors), followed by
centrifugation. Nuclei were resuspended in RIPA 100mM buffer (20mM Tris-HCl
pH 7.5, 100mM NaCl, 1mM EDTA, 0.5% NP-40, 0.5% Na-Deoxycholate,
0.1% SDS supplemented with protease inhibitors). Chromatin was sonicated to
500—800 bp average fragment size and pre-cleared for 1 h at 4 C with protein
A/G PLUS-Agarose (sc-2003). Agarose was removed by centrifugation and an
aliquot of supernatant was taken as input. Chromatin was immunoprecipitated
overnight at 4 C with the following antibodies: mouse monoclonal anti-FLAG M2,
clone M2 (2.5 mgml 1; F1804); mouse monoclonal anti-KMT1A/SUV39H1
(44.1; 2.5 mgml 1; ab12405); rabbit polyclonal anti-trimethyl-Histone H3 (Lys9)
(2.5 mgml 1; 07-442; Millipore); mouse monoclonal anti-HP1a, clone 15.19s2
(2.5 mgml 1; 05-689; Millipore); rabbit polyclonal anti-trimethyl-Histone H4
(Lys20) (2.5 mgml 1; 07-749; Millipore); rabbit polyclonal anti-trimethyl-Histone
H3 (Lys27) (2.5 mgml 1; 07-449; Millipore). As a negative control for immuno-
precipitation, mouse monoclonal anti-HA, clone HA-7 (2.5 mgml 1; H9658)
was used. DNA–protein complexes were recovered with protein A/G PLUS-
Agarose beads and washed with RIPA 100mM buffer, RIPA 250mM buffer
(20mM Tris-HCl pH 7.5, 250mM NaCl, 1mM EDTA, 0.5% NP-40, 0.5%
Na-Deoxycholate and 0.1% SDS), LiCl solution (10mM Tris-HCl pH 8.0, 1mM
EDTA, 250mM LiCl, 0.5% NP-40 and 0.5% Na-Deoxycholate) and 1 TE. RNase
treatment was performed in 1 Tris-EDTA (TE) for 30min at 37 C. Cross-
linking was reversed by overnight incubation at 68 C after adding an equal volume
of proteinase K solution (200mM NaCl, 1% SDS and 0.3mgml 1 proteinase K).
Samples were resuspended in ddH2O after phenol/chloroform extraction and
ethanol precipitation. Co-immunoprecipitated DNA was analysed by RT–PCR
on a StepOnePlus real-time PCR machine, using SYBR Green Universal PCR
Master Mix.
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The oligos used for quantitative RT–PCR are reported below.
Dkk: forward: 50-GGGAACCAGGGAAAGAGGA-30 ; reverse: 50-GGGAAATA
GGCACCCGATAA-30 . Oct4 (primer A): forward: 50-TGCACCCCCTCCTCCTAA
TCC-30 ; reverse: 50-CCCTAAACAAGTACTCAACCC-30 .
Oct4 (primer B): forward: 50-GTTGGGGGGTGGTTAGTGTCT-30; reverse:
50-CCACTCCTCAGTTCTTGCTTA-30 . ChIP data of Oct4 promoter regions were
normalized against input and the Oct4 unrelated DKK gene.
Transient transfection. mESCs and pMEFs were transfected with siRNAs
(ﬁnal concentration, 30 nM) using Lipofectamine RNAiMAX (Life Technologies)
according to the manufacturer’s instructions. siRNA oligonucleotide: mouse Oct4
(Thermo Scientiﬁc Dharmacon; sense sequence: 50-CGGAAGAGAAAGCGA
ACUAUU-30), mouse Suv39h1 (Thermo Scientiﬁc Dharmacon; sense sequence:
50-CCAAUUACCUGGUGCAGAA-30) mouse Oct4P4 (Thermo Scientiﬁc
Dharmacon; sense sequence: 50-GAGCAUGAGUGGAGAGGAA-30) and mouse
Oct4P4#2 (Euroﬁns Genomics; sense sequence: 50-GCCUCUCUUAAGCACUGU
A-30). siGENOME Non-Targeting siRNA#1 (D-001210-01-20, Thermo Scientiﬁc
Dharmacon) and AllStars Negative Control siRNA (1027281; Qiagen; siControl#2)
were used as a negative controls. Transient transfections of plasmids for pMEFs
and U2OS were performed using Lipofectamine 2000 (Life Technologies)
according to the manufacturer’s instructions.
Luciferase reporter assay. The mouse Oct4 promoter, corresponding to 2.9 kb
of genomic region upstream of the Oct4 ATG, was PCR ampliﬁed from mESC
genomic DNA; forward 50-GGGAATTCCTCGAGATTGTACGTAAGTACTT
CAGA-30 ; reverse, 50-GGGAATTCAGATCTGGGGAAGGTGGGCACCCCGA-30
oligonucleotides. For the mouse Oct4P4 promoter reporter construct, 1.8 kb
fragment upstream the Oct4P4 gene was PCR ampliﬁed from mESC genomic DNA;
forward: 50-GGGAATTCCTCGAGCATATGTGTGTCAATCTTGTT-30 ; reverse: 50-
GGGAATTCAGATCTGGGGAAGTTGGGCACCCCAAG-30 . Fragments were
cloned into pGL3Basic (Promega) via XhoI and BglII restriction sites located
upstream of the ﬁreﬂy luciferase gene and sequence veriﬁed. pcDNA3-
HA-OCT4 is reported in ref. 22. For luciferase reporter assays, 4 104 NIH-3T3 cells
were transiently co-transfected with 400ng of pGL3 promoter luciferase reporters and
40ng of CMV-Renilla to normalize for transfection efﬁciency; when indicated, 400 ng
of pCDNA3-HA-Oct4 or pCDNA3-HA vector, and 400ng of pCDNA3-Oct4P4 or
pCDNA3 vector were co-transfected. Transient transfections were performed using
Lipofectamine 2000 according to manufacturer’s instructions. For luciferase reporter
assays involving siRNAs, plasmid DNA was transfected ﬁrst followed by siRNA
transfection after a 16-h recovery period. Fireﬂy/renilla luciferase activity was assayed
72h after transfection using the Dual Luciferase Assay kit (Promega).
Statistical analysis. Each ﬁnding was conﬁrmed by three independent biological
replicates, unless speciﬁed. Error bars represent s.d. All P values were determined
using two-tailed t-tests and statistical signiﬁcance was set at Po0.05. The variance
was similar between groups that we compared.
Uncropped scans of the most important blots are shown in Supplementary
Fig. 9 in the Supplementary Information section.
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